Market Value2,674,291,000
Total Holdings68
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NTLA / Intellia Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
LUNG / Pulmonx Corporation
PMVP / PMV Pharmaceuticals, Inc.
SRRA / Sierra Oncology Inc
NBIX / Neurocrine Biosciences, Inc.
SOPH / SOPHiA GENETICS SA
OM / Outset Medical, Inc.
HCA / HCA Healthcare, Inc.
CANO / Cano Health, Inc.
US00771VAB45 / Aerie Pharmaceuticals Inc
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
JYAC / Jiya Acquisition Corp - Class A
PARDES BIOSCIENCES INC / (69945Q105)
ISHARES TR / CALL Call (464287906)
PFE / Pfizer Inc.
EW / Edwards Lifesciences Corporation
BFLY / Butterfly Network, Inc.
XNTK / SPDR Series Trust - SPDR NYSE Technology ETF Call
BDX / Becton, Dickinson and Company
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
WAT / Waters Corporation
CAH / Cardinal Health, Inc.
MYGN / Myriad Genetics, Inc.
CTLT / Catalent, Inc.
ALNA / Allena Pharmaceuticals Inc
SNDX / Syndax Pharmaceuticals, Inc.
CCCC / C4 Therapeutics, Inc.
CNC / Centene Corporation
ELV / Elevance Health, Inc.
HOWL / Werewolf Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
OSH / Oak Street Health Inc
FLDM / Standard BioTools Inc
GILD / Gilead Sciences, Inc.
AERI / Aerie Pharmaceuticals Inc
INCY / Incyte Corporation
NVAX / Novavax, Inc.
GILD / Gilead Sciences, Inc. Call
MRTX / Mirati Therapeutics, Inc.
KNTE / Kinnate Biopharma Inc.
PRCT / PROCEPT BioRobotics Corporation
BLSA / BCLS Acquisition Corp - Class A
JNCE / Jounce Therapeutics Inc
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
ISEE / IVERIC bio Inc
NVRO / Nevro Corp.
ICUI / ICU Medical, Inc.
RCUS / Arcus Biosciences, Inc.
SGEN / Seagen Inc
TMO / Thermo Fisher Scientific Inc.
ICLR / ICON Public Limited Company
HRTX / Heron Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
KRTX / Karuna Therapeutics, Inc.
SANA / Sana Biotechnology, Inc.
CI / The Cigna Group
HUM / Humana Inc.
PEN / Penumbra, Inc.
BMRN / BioMarin Pharmaceutical Inc.
MCK / McKesson Corporation
CRBU / Caribou Biosciences, Inc.
UHS / Universal Health Services, Inc.
LLY / Eli Lilly and Company
IRTC / iRhythm Technologies, Inc.
ABBV / AbbVie Inc.
CYTK / Cytokinetics, Incorporated
IQV / IQVIA Holdings Inc.
QURE / uniQure N.V.
GBIO / Generation Bio Co.
DHR / Danaher Corporation
VERV / Verve Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
DXCM / DexCom, Inc.
IOBT / IO Biotech, Inc.
THC / Tenet Healthcare Corporation
MOH / Molina Healthcare, Inc.
AVTR / Avantor, Inc.
UNH / UnitedHealth Group Incorporated
ERAS / Erasca, Inc.